AU620866B2 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions Download PDF

Info

Publication number
AU620866B2
AU620866B2 AU33946/89A AU3394689A AU620866B2 AU 620866 B2 AU620866 B2 AU 620866B2 AU 33946/89 A AU33946/89 A AU 33946/89A AU 3394689 A AU3394689 A AU 3394689A AU 620866 B2 AU620866 B2 AU 620866B2
Authority
AU
Australia
Prior art keywords
tablet
approximately
composition according
cimetidine
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU33946/89A
Other languages
English (en)
Other versions
AU3394689A (en
Inventor
Gordon France
Graham Stanley Leonard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP88304008A external-priority patent/EP0294933B1/en
Priority claimed from GB888820265A external-priority patent/GB8820265D0/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of AU3394689A publication Critical patent/AU3394689A/en
Application granted granted Critical
Publication of AU620866B2 publication Critical patent/AU620866B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU33946/89A 1988-05-04 1989-05-02 Pharmaceutical compositions Ceased AU620866B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP88304008A EP0294933B1 (en) 1987-05-08 1988-05-04 Pharmaceutical compositions
GB88304008 1988-05-04
GB8820265 1988-08-26
GB888820265A GB8820265D0 (en) 1988-08-26 1988-08-26 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
AU3394689A AU3394689A (en) 1989-11-09
AU620866B2 true AU620866B2 (en) 1992-02-27

Family

ID=26116144

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33946/89A Ceased AU620866B2 (en) 1988-05-04 1989-05-02 Pharmaceutical compositions

Country Status (14)

Country Link
EP (1) EP0349103B1 (enExample)
JP (1) JP2635407B2 (enExample)
KR (1) KR890016963A (enExample)
AT (1) ATE82680T1 (enExample)
AU (1) AU620866B2 (enExample)
DE (1) DE68903605T2 (enExample)
DK (1) DK214689A (enExample)
ES (1) ES2052911T3 (enExample)
GR (1) GR3006498T3 (enExample)
IE (1) IE62728B1 (enExample)
MY (1) MY104010A (enExample)
NZ (1) NZ228970A (enExample)
PH (1) PH25173A (enExample)
PT (1) PT90466B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
CA2052679C (en) * 1990-08-30 1997-12-02 Edward J. Roche Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
CA2137265C (en) * 1992-06-04 2003-10-28 Sanjay Bhardwaj Palatable pharmaceutical compositions
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
HUT72408A (en) * 1993-09-10 1996-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing tablets containing acetyl-salicylic acid
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
CA2258159C (en) * 1996-06-14 2006-03-21 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablet
US6537525B1 (en) * 1997-01-29 2003-03-25 Douglas H. West Medicated chewing-gum
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
KR20010030798A (ko) * 1997-09-30 2001-04-16 스즈키 다다시 경구 투여 제제
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7842308B2 (en) 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP2004107258A (ja) * 2002-09-18 2004-04-08 Ss Pharmaceut Co Ltd 催眠用圧縮成型製剤
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
MX2007004741A (es) 2004-10-21 2007-09-07 Eurand Pharmaceuticals Ltd Composiciones farmaceuticas con sabor enmascarado con formadores de poro gastrosolubles.
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
JP2006342188A (ja) 2006-09-28 2006-12-21 Rohto Pharmaceut Co Ltd 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物
NZ600256A (en) 2009-12-02 2014-05-30 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
JP2013032408A (ja) * 2012-11-22 2013-02-14 Rohto Pharmaceutical Co Ltd 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
AU602582B2 (en) * 1987-05-08 1990-10-18 Smith Kline & French Laboratories Limited Cimetidine compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES412146A1 (es) * 1972-03-11 1976-01-01 Pfizer Procedimiento de obtencion de composiciones para reducir elhabito del tabaco.
NL7311319A (enExample) * 1972-09-01 1974-03-05
CA1229552A (en) * 1984-07-09 1987-11-24 Audley A. Legore Cimetidine compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601833A (en) * 1978-02-06 1981-11-04 Wellcome Found Antacid formulation
AU602582B2 (en) * 1987-05-08 1990-10-18 Smith Kline & French Laboratories Limited Cimetidine compositions

Also Published As

Publication number Publication date
GR3006498T3 (enExample) 1993-06-21
ES2052911T3 (es) 1994-07-16
IE62728B1 (en) 1995-02-22
IE891414L (en) 1989-11-04
MY104010A (en) 1993-10-30
PT90466A (pt) 1989-11-30
DE68903605D1 (de) 1993-01-07
DK214689D0 (da) 1989-05-02
JP2635407B2 (ja) 1997-07-30
ATE82680T1 (de) 1992-12-15
JPH01313420A (ja) 1989-12-18
EP0349103A1 (en) 1990-01-03
AU3394689A (en) 1989-11-09
PH25173A (en) 1991-03-27
NZ228970A (en) 1991-09-25
PT90466B (pt) 1994-08-31
EP0349103B1 (en) 1992-11-25
DE68903605T2 (de) 1993-04-01
DK214689A (da) 1989-11-05
KR890016963A (ko) 1989-12-14

Similar Documents

Publication Publication Date Title
US5275823A (en) Pharmaceutical compositions
AU620866B2 (en) Pharmaceutical compositions
EP1058538B9 (en) Fast disintegrating tablets
EP1145711B1 (en) Flash-melt oral dosage formulation
US6814978B2 (en) Process for preparing a soft tablet
AU773549B2 (en) Soft chewable tablets
KR100490969B1 (ko) 고형 약학 제제
US5637313A (en) Chewable dosage forms
JP2721219B2 (ja) 医薬組成物
US5169640A (en) Pharmaceutical compositions
KR101438071B1 (ko) 약학 조성물
JPH05112445A (ja) 作用開始を速くし潜在特性を増加させる移送システム
EP0950402A2 (en) Chewable pharmaceutical composition with gelatin matrix
EP2389070B1 (en) Disintegrable formulations of lanthanum carbonate
PL210931B1 (pl) Kompozycja w postaci stałej nadająca się do połykania zawierająca alginian, wodorowęglan i/lub węglan, jej zastosowanie oraz sposób wytwarzania
EP1679066A1 (en) Drug-containing coated microparticle for orally disintegrating tablet
AU4082793A (en) Compositions based on histamine h2-receptor antagonists and cationic exchangers complexes
EP0200252B1 (en) Tablets comprising trimethoprim and a sulfonamide
JPH0656677A (ja) 制酸剤組成物
JP2004175757A (ja) 医薬組成物
HK1074009A (en) Flash-melt oral dosage formulation